Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5779325 | 0.81 | ESR1 (0.37) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL12191041 | 0.78 | MAPT (0.42) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL2524118 | 0.70 | ESR1 (0.39) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL9773556 | 0.69 | ESR1 (0.42) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL9773554 | 0.69 | ESR1 (0.42) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL9773562 | 0.69 | ESR1 (0.42) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL8040579 | 0.68 | ESR1 (0.43) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL707750 | 0.66 | ESR1 (0.44) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL713818 | 0.66 | ESR1 (0.44) | ESR1ESR2NR1H2NR1H3MAPT | |
| SCHEMBL28040715 | 0.66 | ESR1 (0.44) | ESR1ESR2NR1H2NR1H3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658651-A1 | NOVEL COMPOUNDS FOR TAU IMAGING | Eli Lilly and Company (US) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024163546-A1 | NOVEL COMPOUNDS FOR TAU IMAGING | ELI LILLY AND COMPANY (US) | 2024-08-08 | — | — | WO | disclosed |
| WO-2018183601-A1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2018-10-04 | — | — | WO | disclosed |
| EP-2721019-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | Agios Pharmaceuticals, Inc. (US) | 2014-04-23 | — | — | EP | disclosed |
| WO-2012171337-A1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2012-12-20 | — | — | WO | disclosed |
| EP-1619947-A4 | ANTIBACTERIAL METHODS AND COMPOSITIONS | REPLIDYNE INC (US) | 2006-05-31 | — | — | EP | disclosed |
| EP-1619947-A2 | ANTIBACTERIAL METHODS AND COMPOSITIONS | Replidyne, Inc. (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1603881-A2 | SUBSTITUTED THIOPHENES WITH ANTIBACTERIAL ACTIVITY | Replidyne, Inc. (US) | 2005-12-14 | — | — | EP | disclosed |
| EP-1581220-A2 | 2-NH-HETEROARYLIMIDAZOLES WITH ANTIBACTERIAL ACTIVITY | Replidyne, Inc. (US) | 2005-10-05 | — | — | EP | disclosed |
| WO-2005009336-A9 | ANTIBACTERIAL METHODS AND COMPOSITIONS | REPLIDYNE INC (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2005009336-A2 | ANTIBACTERIAL METHODS AND COMPOSITIONS | REPLIDYNE, INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| WO-2004078119-A2 | SUBSTITUTED THIOPHENES WITH ANTIBACTERIAL ACTIVITY | REPLIDYNE INC. (US) | 2004-09-16 | — | — | WO | disclosed |
| WO-2004052288-A2 | 2-NH-HETEROARYLIMIDAZOLES WITH ANTIBACTERIAL ACTIVITY | REPLIDYNE, INC. (US) | 2004-06-24 | — | — | WO | disclosed |